Trogarzo Injection, Solution
Product Images NDC 62064-122

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Trogarzo (NDC 62064-122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Theratechnologies Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Trogarzo Vial Label)

FDA Label Image

Principal Display Panel (Trogarzo Carton Label)

Principal Display Panel (Trogarzo Carton Label)
This is a product description for a medication called Trogarzo, also known as ibalizumab-uiyk. It is available in single-dose vials for intravenous infusion and comes in two strengths: 200mg/1.33mL and 150mg/mL. The medication should be discarded if any portion is unused. The package contains information about Trogarzo, including its dosage and storage instructions. This text appears to be a scan of the product label or packaging.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.